Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Queensland Health
Federal Trade Commission
Chinese Patent Office
US Army
Citi

Generated: July 22, 2019

DrugPatentWatch Database Preview

Patent: 8,603,482

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,603,482
Title:Compositions and methods for cancer immunotherapy
Abstract: The invention relates to immunotherapeutic compounds and to methods for stimulating an immune response in a subject individual at risk for developing cancer, diagnosed with a cancer, in treatment for cancer, or in post-therapy recovery from cancer or the compounds of the invention can be administered as a prophylactic to a subject individual to prevent or delay the development of cancer.
Inventor(s): Rossignol; Daniel P. (Ridgefield Park, NJ), Ishizaka; Sally T. (Weston, MA), Hawkins; Lynn D. (Andover, MA), Fields; Scott (Towaco, NJ)
Assignee: Eisai R&D Management Co., Ltd. (Bunkyo-Ku, Tokyo, JP)
Application Number:13/158,786
Patent Claims:see list of patent claims

Details for Patent 8,603,482

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech PERJETA pertuzumab VIAL; SINGLE-USE 125409 001 2012-06-08 ➤ Try a Free Trial Eisai R&D Management Co., Ltd. (Bunkyo-Ku, Tokyo, JP) ➤ Try a Free Trial RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26 ➤ Try a Free Trial Eisai R&D Management Co., Ltd. (Bunkyo-Ku, Tokyo, JP) ➤ Try a Free Trial RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26 ➤ Try a Free Trial Eisai R&D Management Co., Ltd. (Bunkyo-Ku, Tokyo, JP) ➤ Try a Free Trial RX search
Imclone ERBITUX cetuximab VIAL; INTRAVENOUS 125084 001 2004-06-18 ➤ Try a Free Trial Eisai R&D Management Co., Ltd. (Bunkyo-Ku, Tokyo, JP) ➤ Try a Free Trial RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
UBS
Cantor Fitzgerald
Chinese Patent Office
Deloitte
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.